Table 1.
Patient baseline demographics and clinical characteristics
| Characteristic | N=29 |
|---|---|
| Sex, male | 21 (72.4) |
| Age, years (mean±SD) | 62.8±9.2 |
| ≥65 years | 13 (44.8) |
| Dry weight, kg (mean±SD) | 58.4±13.1 |
| Body mass index, kg/m2 (mean±SD) | 22.9±3.2 |
| Duration of dialysis, months (mean±SD) | 149.4±122.6 |
| Previous use of cinacalcet | |
| Cinacalcet hydrochloride | 14 (48.3) |
| Other calcimimetics | 3 (10.3) |
| Primary disease | |
| Diabetic nephropathy | 7 (24.1) |
| Chronic glomerulonephritis | 14 (48.3) |
| Nephrosclerosis | 2 (6.9) |
| Comorbidities | |
| Diabetes | 7 (24.1) |
| Type of dialysis | |
| Hemodialysis | 24 (82.8) |
| Hemodiafiltration | 5 (17.2) |
| Intact PTH, pg/mL (mean±SD) | 271.3±109.1 |
| Corrected calcium, mg/dL (mean±SD) | 9.78±0.50 |
| Phosphorus, mg/dL (mean±SD) | 4.76±0.79 |
| Intact FGF23, pg/mL (mean±SD) | 12,131.2±13,101.2 |
Note: Values are shown as n (%) unless otherwise specified.
Abbreviations: FGF23, fibroblast growth factor 23; PTH, parathyroid hormone.